Introduction
============

Mild cognitive impairment (MCI) is a transitional step between normal cognition and dementia, in which patients have objective disturbances and cognitive complaints on cognitive examinations, but in which their ability to carry out daily life activities are not affected ([@B20]; [@B18]). Once MCI becomes more advanced, pharmacological interventions targeted at dementia are unlikely to delay further cognitive impairment ([@B39]; [@B6]), consequently, exploring the risk factors of MCI and its development mechanism is of great significance for the reduction of cognitive morbidity.

Dipeptidyl peptidase-4 (DPP4) is a serine exopeptidase belonging to the S9b DPP family that exists as a membrane-anchored cell surface protein or circulates as a soluble form in the peripheral circulation ([@B34], [@B37]). Our previous data and other evidence in human or animals studies all proved that higher levels of DPP4 resulted in the enhancement of inflammation and oxidative stress, both of which have been implicated in the pathophysiology of cognitive decline ([@B10]; [@B31],[@B32],[@B33]). More importantly, our previous data demonstrated that plasma DPP4 activity was significantly and independently associated with MCI in subjects with normal glucose tolerance and the mechanisms may be explained by the mutual influence between oxidative stress and DPP4 ([@B6]). The BDNF, a member belonging to the neurotrophic superfamily of growth factors, plays a pivotal role in neuronal survival and repair, dendrite pruning and synaptic plasticity maintenance ([@B9]). A meta-analysis study indicated that MCI patients were accompanied by decreased circulating levels of BDNF, suggesting a link between reduced BDNF and the increased risk of MCI ([@B21]). Since increased circulating levels of DPP4 activity and decreased BDNF might both have been implicated in the pathophysiology of MCI, it is reasonable to speculate that BDNF might be inversely related to DPP4 activity and DBR might be considered as a novel biomarker for MCI in the elderly population with normal glucose tolerance. However, no study has ever investigated the relationship between BDNF and DPP4 activity or the feasibility of identifying DPP4 activity in the BDNF ratio as a novel biomarker for MCI in subjects with normal glucose tolerance.

Therefore, the aim of this study was to determine (1) whether plasma DPP4 activity is inversely related to, (2) what factors might mediate this inverse relationship, (3) whether DBR could be considered as a novel biomarker for MCI. Previous studies have found significant correlations between hyperglycemia and DPP4 activity, BDNF and cognitive impairment ([@B11]; [@B13]; [@B35]), to exclude the possible influences of hyperglycemia on DPP4 activity, BDNF and cognitive function. Our study was conducted in a non-diabetic population.

Materials and Methods {#s1}
=====================

Subjects
--------

The study participants included 1066 elderly non-diabetic subjects aged 60 years or older, who visited the Medical Examination Department of the Affiliated Hospital of Guilin Medical University, between 2013 and 2016. Subjects were excluded if they met any of the following criteria: (1) presence of diseases comprising of hyperglycemia, head trauma, hypertensive crisis, malignancy, hypothyroidism, non-alcoholic fatty liver disease, chronic or acute inflammatory diseases, dementia, heart, liver, respiratory, and kidney dysfunction, (2) history of psychological disturbances, visual/auditory disorders and central nervous system disease that might result in dementia, (3) those who had taken medication affecting circulating levels of DPP4 activity or cognitive function within one year before enrollment, (4) drug or alcohol abuse. Our study was approved by the Drugs and Medical Apparatus Ethics Committee at the Affiliated Hospital of Guilin Medical University, and all participants provided signed written informed consent (Trial Registration Number: ChiCTR-EPC-14005273).

Data Collection
---------------

Demographic and clinical data were recorded in a standardized interview by trained staff. Venous blood specimen was collected from fasting participants to measure circulating levels of CRP, IL-6, 8-iso-PGF2a, nitrotyrosine, BDNF, and DPP4 activity. The plasma levels of BDNF were determined using an ELISA kit (R&D, United States), BDNF concentrations were obtained against a standard curve and expressed as ng/ml. DPP4 activity, 8-iso-PGF2a, nitrotyrosine, CRP, and IL-6 were assayed as previously described ([@B35], [@B31]). MCI was determined by the MoCA and finally confirmed by neurologists ([@B2]). MoCA tests eight cognitive domains, visual--spatial ability, attention, executive function, immediate memory, delayed memory, language, abstraction, calculation, and orientation-for a maximum total score of 30. The normal MoCA score is ≥26, with 1 point added if the subject has fewer than 12 years of formal education ([@B17]; [@B39]).

Statistical Analysis
--------------------

Statistical analyses were performed with SPSS version 16.0. Data were presented as proportions, frequencies, median (interquartile range) or mean ± standard deviation. We used the *t*-test, chi-square and ANCOVA to compare clinical and biochemical parameters. ANCOVA was conducted to compare continuous variables across DBR quartiles after adjusting for age, gender, and BMI. The relationships between parameters were investigated with partial correlation analysis and multivariate logistic regression analysis.

Mediation analysis was conducted as follows: (1) *Y* = cX + e1 (2) *M* = aX + e2 (3) *Y* = c'X + bM + e3, X represents DPP4 activity, *Y* represents BDNF, *M* represents the mediator, a represents the regression coefficient for the relationship between DPP4 activity and mediator, b represents the regression coefficient for the relationship between mediator and BDNF, c represents the regression coefficient for the relationship between DPP4 and BDNF, and c' represents the direct effect of DPP4 on BDNF after controlling for the indirect effect. A Sobel Test was conducted to further test mediation. An indirect ratio was calculated to estimate the strength of mediation: (\[a^∗^b\]/c) ([@B28]; [@B36]).

Results
=======

Clinical and Laboratory Characteristics
---------------------------------------

[Table 1](#T1){ref-type="table"} shows the characteristics of all participants according to DBR quartiles. Participants with higher DBRs were relatively old (*P* \< 0.05), with a lower BDNF and MoCA score and higher 8-iso-PGF2a, nitrotyrosine, CRP, IL-6 and DPP4 activity (all *P* \< 0.05). Compared with controls, subjects with MCI had a lower BDNF and MoCA score and higher 8-iso-PGF2a, nitrotyrosine, DPP4 activity and a DBR ([Supplementary Table 1](#SM3){ref-type="supplementary-material"}). Compared with male participants, female participants had higher BDNF levels (*P* \< 0.01) (2.36 ± 1.11 ng/ml in men vs. 2.65 ± 1.07 ng/ml in women) ([Supplementary Figure S2](#SM2){ref-type="supplementary-material"}).

###### 

Characteristics of study participants according to quartiles of the DPP4 activity to BDNF ratio (DBR).

  Characteristics                      Total              Q1                 Q2                 Q3                 Q4                 *P*-value
  ------------------------------------ ------------------ ------------------ ------------------ ------------------ ------------------ -----------
  DBR                                  10.06 ± 9.65       2.68 ± 0.83        5.34 ± 0.82        9.25 ± 1.58        23.02 ± 11.12      \<0.001
  Age(years)                           68.9 ± 5.4         68.7 ± 5.1         68.2 ± 5.6         69.1 ± 5.4         69.5 ± 5.5         0.044
  Percent men (%)                      41.8               39.7               38.0               41.2               48.5               0.071
  Body mass index (kg/m^2^)            23.3 ± 3.7         22.6 ± 3.6         23.3 ± 3.6         23.4 ± 3.7         23.9 ± 3.9         0.001
  Current smoking (%)                  20.2               18.0               17.7               20.2               24.8               0.145
  Habitual alcohol drinking (%)        17.2               14.6               17.3               16.1               20.7               0.290
  Leisure-time physical activity (%)   56.8               58.4               57.5               54.7               56.8               0.842
  Education level                                                                                                                     0.398
  ≤Primary school                      49.0               44.6               50.8               49.8               50.8               
  Middle school                        42.6               47.9               40.2               43.1               39.1               
  ≥High school                         8.4                7.5                9.0                7.1                10.1               
  Annual income, RMB                                                                                                                  0.227
  ≤5000                                4.8                3.7                4.5                5.2                5.6                
  5000--30000                          45.4               45.0               44.0               51.7               41.0               
  \>30000                              49.8               51.3               51.5               43.1               53.4               
  Statin use (%)                       11.3               10.5               9.8                12.0               12.8               0.681
  NSAID use (%)                        6.2                5.2                5.3                6.7                7.5                0.625
  Cardiovascular disease (%)           7.9                7.5                6.8                6.7                10.5               0.314
  SBP^a^                               120 ± 19           119 ± 16           119 ± 18           122 ± 20           121 ± 22           0.488
  DBP^a^                               71 ± 9             71 ± 8             71 ± 8             70 ± 9             70 ± 10            0.503
  TG (mmol/L)^a^                       1.45 (1.10,1.98)   1.31 (0.99,1.84)   1.35 (0.99,1.91)   1.50 (1.17,2.01)   1.61 (1.27,2.15)   0.002
  TC (mmol/L)^a^                       5.14 ± 0.95        5.04 ± 0.88        5.16 ± 0.96        5.18 ± 0.99        5.16 ± 0.98        0.499
  LDL-C (mmol/L)^a^                    3.05 ± 0.89        2.99 ± 0.90        3.11 ± 0.90        3.08 ± 0.87        3.00 ± 0.90        0.508
  HDL-C (mmol/L)^a^                    1.40 ± 0.37        1.39 ± 0.40        1.44 ± 0.38        1.41 ± 0.36        1.36 ± 0.37        0.268
  IL-6 (pg/ml)^a^                      1.36 (1.11,1.60)   1.31 (1.07,1.48)   1.29 (1.03,1.46)   1.38 (1.16,1.64)   1.53 (1.23,1.90)   \<0.001
  CRP (mg/L)^a^                        1.16 (0.94,1.34)   1.09 (0.86,1.25)   1.15 (0.92,1.29)   1.19 (0.97,1.41)   1.23 (0.97,1.58)   \<0.001
  Nitrotyrosine (μmol/L)^a^            0.39 ± 0.12        0.34 ± 0.10        0.36 ± 0.10        0.40 ± 0.12        0.47 ± 0.13        \<0.001
  8-iso-PGF2a (pg/mL)^a^               42.5 ± 10.8        36.3 ± 9.6         41.1 ± 9.7         43.6 ± 10.7        49.2 ± 8.8         \<0.001
  DPP4 activity (nmol/min/ml)^a^       18.1 ± 8.1         9.7 ± 3.5          15.0 ± 3.9         20.1 ± 4.7         27.5 ± 6.3         \<0.001
  BDNF (ng/ml)^a^                      2.53 ± 1.10        3.70 ± 0.90        2.84 ± 0.76        2.21 ± 0.53        1.35 ± 0.47        \<0.001
  MoCA score^a^                        26.9 ± 2.4         27.9 ± 2.0         27.2 ± 2.2         26.8 ± 2.1         25.8 ± 2.7         \<0.001

Data were expressed as means ± standard deviation, median (interquartile range), or percentage for normally distributed continuous various, abnormally distributed continuous variables (TG, IL-6, CRP), and categorical variables, respectively. Cigarette smoking was defined as having smoked at least 100 cigarettes in one's lifetime. Regular leisure-time physical activity was defined as participation in ≥30 min of moderate or vigorous activity per day at least 3 days per week.

a

Adjusted for age, gender, and BMI

.

The Relationships Between DBR and Other Parameters
--------------------------------------------------

Partial correlation analyses revealed that (1) DPP4 was inversely related to BDNF in all participants, (2) 8-iso-PGF2a, nitrotyrosine, CRP, and IL-6 were all positively correlated with DBR and DPP4 activity and negatively with BDNF, (3) BDNFs were positively associated, and DPP4 and DBRs negatively, with the MoCA score ([Table 2](#T2){ref-type="table"}).

###### 

Correlations between DPP4 activities, BDNF, and DBR vs. metabolic parameters and MoCA score.

                  DPP4 activity^a^   BDNF^a^   DBR^a^                      
  --------------- ------------------ --------- -------- --------- -------- ---------
  DPP4 activity   \-                 \-        -0.456   \<0.001   0.750    \<0.001
  BDNF            -0.456             \<0.001   \-       \-        -0.688   \<0.001
  IL-6            0.299              \<0.001   -0.137   \<0.001   0.215    \<0.001
  CRP             0.225              \<0.001   -0.129   \<0.001   0.218    \<0.001
  nitrotyrosine   0.304              \<0.001   -0.415   \<0.001   0.362    \<0.001
  8-iso-PGF2a     0.328              \<0.001   -0.471   \<0.001   0.407    \<0.001
  MoCA score      -0.306             \<0.001   0.209    \<0.001   -0.254   \<0.001

a

P-value determined by partial correlation analysis with respect to the DPP4 activity, BDNF, and DBR adjusted for age, BMI, gender, education level, statin use and NSAID use

.

Mediation Analysis
------------------

[Figure 1A,B](#F1){ref-type="fig"} presented the mediating role of 8-iso-PGF2a and nitrotyrosine in the negative correlation between DPP4 and BDNF in all subjects, in the first model, 8-iso-PGF2a and nitrotyrosine were both positively correlated with DPP4 activity (*P* \< 0.01), in the second model, BDNF was inversely correlated with DPP4 activity (*P* \< 0.01), in the third model, DPP4 activity, nitrotyrosine or 8-iso-PGF2a were all inversely correlated with BDNF (*P* \< 0.01). A Sobel test revealed that 8-iso-PGF2a and nitrotyrosine both had an indirect effect, representing 20.4 and 26.0% of the total effect on the correlation between BDNF and DPP4 activity, respectively. When the participants were further divided into two subgroups according to gender, the results of the mediating role of oxidative stress parameters in the inverse correlation between DPP4 activity and BDNF in male and female participants showed similar results ([Figure 1C](#F1){ref-type="fig"}--[F](#F1){ref-type="fig"}), such that 8-iso-PGF2a and nitrotyrosine were partial mediators in both male and female subjects, the percentages of the indirect effect mediated by 8-iso-PGF2a and nitrotyrosine were 22.9 and 19.3% in women and 29.3 and 20.8% in men, respectively. The mediating role of inflammatory markers in the negative correlation between BDNF and DPP4 activity were also tested ([Supplementary Figure S1](#SM1){ref-type="supplementary-material"}), in the third model, both CRP and IL-6 were not significantly correlated with BDNF, therefore, inflammation markers did not play a mediating role in the negative relationship between DPP4 activity and BDNF.

![Oxidative stress mediation models of the relationship between plasma DPP4 activity and BDNF. **(A)** Nitrotyrosine mediation models of the relationship between plasma DPP4 activity and BDNF in all participants. **(B)** 8-iso-PGF2a mediation models of the relationship between plasma DPP4 activity and BDNF in all participants. **(C)** Nitrotyrosine mediation models of the relationship between plasma DPP4 activity and BDNF in men. **(D)** 8-iso-PGF2a mediation models of the relationship between plasma DPP4 activity and BDNF in men. **(E)** Nitrotyrosine mediation models of the relationship between plasma DPP4 activity and BDNF in women. **(F)** 8-iso-PGF2a mediation models of the relationship between plasma DPP4 activity and BDNF in women. ^∗^*P* \< 0.05, ^∗∗^*P* \< 0.01.](fnagi-11-00033-g001){#F1}

Associations Between DBR and MCI
--------------------------------

The prevalence of MCI in this study was 15.9%. The odds ratio for MCI were higher with decreasing BDNF quartiles and increasing DBR and DPP4 quartiles. The odds ratio for MCI in the highest quartiles of DBR, DPP4 and BDNF were as follows: 4.63 for DBR, 3.78 for DPP4 and 0.28 for BDNF (*P* \< 0.01) ([Table 3](#T3){ref-type="table"}). The odds ratio for MCI became higher in subjects with lower BDNF and higher DPP4 activity ([Figure 2](#F2){ref-type="fig"}).

###### 

Logistic regression analysis of the association of DPP4 activity, BDNF, DBR, and MCI.

                                Q1           Q2                        Q3                           Q4
  ----------------------------- ------------ ------------------------- ---------------------------- ----------------------------
  DPP4 activity (nmol/ml/min)   \<11.97      11.97-16.87               16.88-24.02                  \>24.02
  MCI                           21 (7.9%)    40 (15.0%)                39 (14.6%)                   69 (25.9%)
  Model 1                       1            2.06 (1.18, 3.59) 0.011   2.00 (1.14, 3.50) 0.016      4.09 (2.42, 6.90) \< 0.001
  Model 2                       1            1.88 (1.06, 3.33) 0.030   2.00 (1.12, 3.56) 0.018      3.78 (2.20, 6.49) \< 0.001
  BDNF (ng/ml)                  \<1.71       1.71-2.37                 2.38-3.22                    \>3.22
  MCI                           70 (26.2%)   50 (18.7%)                26 (9.8%)                    23 (8.6%)
  Model 1                       1            0.65 (0.43, 0.98) 0.039   0.31 (0.19, 0.50) \< 0.001   0.27 (0.16, 0.44) \< 0.001
  Model 2                       1            0.69 (0.45, 1.06) 0.091   0.31 (0.19, 0.51) \< 0.001   0.28 (0.17, 0.48) \< 0.001
  DBR                           \<4.01       4.01-6.86                 6.87-12.28                   \>12.28
  MCI                           21 (7.9%)    31 (11.7%)                39 (14.6%)                   78 (29.3%)
  Model 1                       1            1.55 (0.86, 2.77) 0.143   2.00 (1.14, 3.51) 0.015      4.86 (2.90, 8.16) \< 0.001
  Model 2                       1            1.52 (0.84, 2.74) 0.165   1.94 (1.10, 3.43) 0.023      4.63 (2.73, 7.88) \< 0.001

Model 1, crude model; Model 2, Model 1 + age + gender + BMI + current smoking + habitual alcohol consumption + leisure-time physical activity + education level + annual income + statin use + NSAID use + cardiovascular disease + SBP + TG + HDL-C

.

![Adjusted ORs for MCI according to the quartiles of DPP4 activity and BDNF.](fnagi-11-00033-g002){#F2}

Discussion
==========

The novel findings of this study were that (1) circulating levels of BDNF were inversely correlated with DPP4 activity, (2) the inverse correlation between BDNF and DPP4 was partially mediated by oxidative stress, not inflammation (3) higher levels of DBR and DPP4 activity and lower levels of BDNF were positively related to the increased risk of MCI.

Previous researches suggested that decreased BDNF and increased DPP4 activities were found in the periphery circulation of patients with MCI ([@B39]; [@B21]), suggesting that BDNF and DPP4 activity might both play a pathogenetic role in the development of cognitive impairment. Consistently, our current study also found that MCI patients with normal glucose tolerance had lower BDNF and higher DPP4 activity in periphery circulation, compared with the controls. More importantly, an inverse correlation was found between BDNF and DPP4 activity in this study, since oxidative stress and inflammation have both been suggested to be linked to DPP4 and BDNF, we used mediation analyses to test whether this inverse correlation between BDNF and DPP4 activity was mediated by inflammation and oxidative stress. In this study, CRP and IL-6 were chosen as inflammatory markers and 8-iso-PGF2a and nitrotyrosine were chosen as oxidative stress parameters, respectively. The reason for this selection could be summarized as follows: (1) there is growing evidence linking cognitive function with proinflammatory markers, in particular the downstream CRP and the upstream cytokines IL-6 ([@B14]; [@B23]), CRP and IL-6 were both found to be predictive of future cognitive impairment in previous studies ([@B26]; [@B12]). (2) 8-iso-PGF2a and nitrotyrosine have both been validated to accurately assess the level of oxidative stress in human studies ([@B4], [@B5]).

Accumulated basic and clinical evidence have demonstrated that DPP4 dose-dependently increased oxidative stress production ([@B10]; [@B32]). More importantly, previous studies have proved that DPP4 inhibitors, such as Alogliptin or Vildagliptin, suppressed oxidative stress in different animal models ([@B1]; [@B29]; [@B3]; [@B30]). With regard to the association between oxidative stress and BDNF, oxidative stress has been proven to cause a decrease in BDNF expression in basic research, while the underlying mechanisms was partly attributed to the impairment of N-methyl-[D]{.smallcaps}-aspartate channel ([@B27]). In this study, our findings from mediation analyses were consistent with previous reports, that DPP4 activity were positively related, and BDNF negatively, to oxidative stress parameters in the linear regression model, furthermore, oxidative stress parameters 8-iso-PGF2a and nitrotyrosine both played a mediating role in the negative correlation between BDNF and DPP4 activity, with indirect effects contributing 20.4 and 26.0% of the total effect, respectively. Since a gender difference exists in BDNF levels in periphery circulation ([@B25]), we further divided all participants into two subgroups according to gender, and mediation analysis showed that the percentages of oxidative stress-mediated indirect effects in men were higher than that in women, this result might be partly due to the fact that circulating levels of BDNF in men were lower than in women. In addition, a gender difference has also been reported for DPP4 activity ([@B8]), Durinx et al. proved that plasma DPP4 activity in women was slightly lower than in men. However, in this study, we did not find a gender difference in plasma DPP4 activity (18.3 ± 8.4 nmol/min/ml in men vs. 17.9 ± 7.9 nmol/min/ml in women), this discrepancy might partly be attributed to differences in sample size, study design, medicine status, race and use of DPP4 activity kits. We cannot rule out the possibility that the higher percentages of oxidative stress-mediated indirect effects in men might be partly due to the higher plasma DPP4 activity in men as well.

The relationships between DPP4, BDNF and inflammation have also been extensively investigated. The proinflammatory effects of DPP4 and its underlying mechanism have been well addressed ([@B24]; [@B22]; [@B41]; [@B33]; [@B40]; [@B7]), consistently, throughout this study, and a positive relationship was found between IL-6, CRP and DPP4 activity. Results regarding the correlation between BDNF and inflammation were more complicated and inconsistent, on one hand, inflammation could lead to both an increase and a decrease in BDNF production at different organ tissues, on the other hand, BDNF might in turn exert pro- and anti-inflammatory influences ([@B19]). The inconsistencies in previous studies regarding the relationship between inflammation and BDNF might be partly attributed to mutual interactions between BDNF and inflammation at different parts of the human body. In this study, partial correlation controlling for possible confounders proved a negative correlation between BDNF and inflammation markers, however, when both inflammation markers and DPP4 activity were simultaneously added in the linear regression model, no significant relationship was found between BDNF and inflammation markers, consequently, these results suggested that inflammation did not play a mediating role in the inverse correlation between BDNF and DPP4 activity.

Logistic regression analysis proved that participants in the lowest quartile of BDNF and the highest quartiles of DBR and DPP4 activity had the highest MCI risk, more importantly, the MCI risk in the lowest quartile of BDNF and the highest quartile of DPP4 activity were lower than that in the highest quartile of DBR, suggesting that the combination of BDNF and DPP4 activity, which presented as DBR, might be more suitable to serve as a risk biomarker for MCI than either BDNF or DPP4 activity alone. Based on these findings above, we extrapolated that increased DPP4 activity might result in the enhancement of oxidative stress, leading to a decrease in BDNF expression. This, in turn, impaired neuronal survival and synaptic plasticity maintenance and finally promoted the development of MCI. However, further studies are needed to clarify this speculation.

There were some limitations to our study, (1) since this study was a cross-sectional research, inferences about causalities are limited, (2) some unknown factors other than oxidative stress might also exist to mediate the negative correlation between BDNF and DPP4, (3) the presence of some unmeasured confounders may also have had some effects on the relationship between MCI and DBR limiting generalizations of this study, however, after adding a wide range of potential confounders in the statistical analyses, the strong relationship between DBR and MCI are unlikely to be an artifact, (4) we failed to discuss how other diseases may influence DBR. Previous studies have reported higher levels of DPP4 activity in patients with diabetes, obesity and depression ([@B35], [@B38]; [@B16]), in addition, diabetic and depressive patients both exhibited lower levels of BDNF in the circulation ([@B11]; [@B15]), therefore, whether DBR could be used as a novel risk biomarker for MCI in patients with diabetes, obesity and depression remains to be clarified in further research.

In conclusion, our current data supported the negative relationship between BDNF and DPP4 activity in MCI, from a clinical perspective, we extrapolated that this negative relationship was partly mediated by oxidative stress, not inflammation. In particular, DBR might be more suitable to serve as a risk biomarker for MCI than either BDNF or DPP4 activity alone, in an elderly non-diabetic population. However, because of the nature of this study, the feasibility of identifying DBR as a novel biomarker or even a therapeutic target for MCI still needs to be confirmed by future studies.
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Inflammation mediation models of the relationship between plasma DPP4 activity and BDNF **(A)** IL-6 mediation models of the relationship between plasma DPP4 activity and BDNF in all participants. **(B)** CRP mediation models of the relationship between plasma DPP4 activity and BDNF in all participants. **(C)** IL-6 mediation models of the relationship between plasma DPP4 activity and BDNF in men. **(D)** CRP mediation models of the relationship between plasma DPP4 activity and BDNF in men. **(E)** IL-6 mediation models of the relationship between plasma DPP4 activity and BDNF in women. **(F)** CRP mediation models of the relationship between plasma DPP4 activity and BDNF in women. ^∗^*P* \< 0.05, ^∗∗^*P* \< 0.01.
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Comparison of BDNF levels between men and women. ^∗^*P* \< 0.05, ^∗∗^*P* \< 0.01.
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Characteristics of the 1066 participants by MCI.
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